The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
This was the stock's second consecutive day of losses.
The Feb. 21 cyberattack on Change Healthcare crippled financial operations for hospitals, insurers, pharmacies and medical groups nationwide. In July, the organization began sending out breach ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...
The ASC industry is facing two new, opposing forces: consolidation by large ASC chains and independent ASCs with non-traditional business models.
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
The FTC accused the "Big Three" pharmacy benefit managers (PBMs) — UnitedHealth Group's Optum Rx, CVS Health's Caremark and ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
Change Healthcare says the breach may have exposed health information, payment information, and personal details like social ...
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The FTC filed a lawsuit on Friday, alleging three largest pharmacy benefit managers “artificially" inflated the cost of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback